Literature DB >> 25348990

Inflammatory bowel disease in pregnancy: management strategy based on best evidence and European guidelines.

Yukiko Kubota-Sjogren1, Kate Harding2, Peter Irving3, Catherine Nelson-Piercy4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25348990      PMCID： PMC4220215          DOI： 10.3399/bjgp14X682513

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  3 in total

1.  European evidenced-based consensus on reproduction in inflammatory bowel disease.

Authors:  C Janneke van der Woude; Sanja Kolacek; Iris Dotan; Tom Oresland; Séverine Vermeire; Pia Munkholm; Uma Mahadevan; Lucy Mackillop; Axel Dignass
Journal:  J Crohns Colitis       Date:  2010-09-15       Impact factor: 9.071

Review 2.  Pregnancy related issues in inflammatory bowel disease: evidence base and patients' perspective.

Authors:  Christian P Selinger; Rupert Wl Leong; Simon Lal
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

3.  No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.

Authors:  Corinna Weber-Schoendorfer; Maria Hoeltzenbein; Evelin Wacker; Reinhard Meister; Christof Schaefer
Journal:  Rheumatology (Oxford)       Date:  2013-12-24       Impact factor: 7.580
  3 in total
  1 in total

1.  Drug-Drug Compatibility Evaluation of Sulfasalazine and Folic Acid for Fixed-Dose Combination Development Using Various Analytical Tools.

Authors:  Mario-Livio Jeličić; Edvin Brusač; Stanislav Kurajica; Matija Cvetnić; Daniela Amidžić Klarić; Biljana Nigović; Ana Mornar
Journal:  Pharmaceutics       Date:  2021-03-17       Impact factor: 6.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.